Lazard Asset Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,207
Closed -$119K 2316
2024
Q4
$119K Buy
3,207
+1,031
+47% +$48.1K ﹤0.01% 1749
2024
Q3
$108K Buy
2,176
+1,237
+132% +$48.1K ﹤0.01% 1761
2024
Q2
$32K Buy
939
+667
+245% +$26.4K ﹤0.01% 1986
2024
Q1
$14K Sell
272
-11
-4% -$545 ﹤0.01% 1860
2023
Q4
$12K Buy
283
+3
+1% +$93 ﹤0.01% 2086
2023
Q3
$7K Sell
280
-18,575
-99% -$386K ﹤0.01% 2160
2023
Q2
$451K Buy
18,855
+18,631
+8,317% +$321K ﹤0.01% 1148
2023
Q1
$3K Hold
224
﹤0.01% 2178
2022
Q4
$3K Buy
+224
New +$3.16K ﹤0.01% 2267

Other funds holding BHVN

Lazard Asset Management's BHVN Position: Q1 2025 in Review

Lazard Asset Management sold out of Biohaven (BHVN) in Q1 2025, closing a stake of 3,207 shares — an estimated $119K sold.

Lazard Asset Management first reported a position in BHVN in Q4 2022 and held it in 9 quarters. The position peaked at $451K in Q2 2023. 266 funds tracked by Wall St. Rank hold BHVN as of Q1 2025.

  • Lazard Asset Management reported no remaining Biohaven position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 3,207 Biohaven shares in Q1 2025, an estimated $119K.
  • Lazard Asset Management first reported a position in Biohaven in Q4 2022 and held it in 9 quarters.
  • Lazard Asset Management's Biohaven position peaked at $451K in Q2 2023.
  • 266 funds tracked by Wall St. Rank held Biohaven as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.